Evidence-informed content. Review status is maintained by the editorial team.
Premenstrual syndrome is a recurring group of physical and emotional symptoms in the luteal phase that improve after menstruation begins.
Signs and symptoms
Bloating, breast tenderness, headache, irritability, mood change and sleep difficulty may occur.
Features associated with premenstrual syndrome can overlap with other reproductive, pregnancy or general health conditions. Timing, severity, pregnancy status and effects on daily function guide assessment.
Causes
The causes of premenstrual syndrome vary and may involve hormonal, anatomical, genetic, infectious, inflammatory or life-stage factors. Symptoms cannot establish the cause without appropriate assessment.
Risk factors
Risk factors may change the likelihood of premenstrual syndrome but do not confirm it. Many affected people have no recognised risk factor, and many people with risk factors do not develop the condition.
Diagnosis
Prospective symptom tracking over at least two cycles supports diagnosis. Exercise, sleep, cognitive behavioural strategies and selected medicines may help.
Assessment of premenstrual syndrome may include pregnancy status, medical and reproductive history, medicines, examination and targeted testing. Online information cannot provide an individual diagnosis.
Treatment
Treatment for premenstrual syndrome is individualised around the cause, severity, reproductive goals, pregnancy or breastfeeding status and personal preferences. Medicine or procedures require informed discussion of benefits and risks.
Self-care
For premenstrual syndrome, self-care can support but not replace appropriate assessment. Follow the agreed care plan, use medicines only as directed, keep concise symptom records and seek review when recovery is not progressing.
Recovery
Recovery from premenstrual syndrome varies with cause and treatment. Gradual improvement, follow-up results and return of comfortable daily function are more useful than a fixed timetable.
Prevention
Not every case of premenstrual syndrome can be prevented. Routine reproductive and maternity care, vaccination, infection prevention, medicine review and early attention to symptoms can reduce avoidable complications where applicable.
Possible complications
Possible complications of premenstrual syndrome depend on severity and context. Persistent bleeding, infection, anaemia, pain, feeding difficulty or reproductive effects deserve professional review rather than assumption.
When to seek urgent medical care
Urgent professional support is needed for an immediate safety concern, severe confusion, chest symptoms or sudden neurological signs.
If someone with possible premenstrual syndrome seems seriously unwell, seek urgent care. Call the local emergency number for collapse, unresponsiveness, severe breathing difficulty or another immediate threat to life.
Frequently asked questions
Can symptoms confirm the condition?
No. Symptoms associated with premenstrual syndrome may have several causes, and examination or tests may be needed before care is chosen.
Can self-care replace professional assessment?
Self-care may support mild, assessed premenstrual syndrome, but it cannot replace evaluation when symptoms worsen, warning signs appear or pregnancy is possible.
When should follow-up be arranged?
Arrange follow-up for premenstrual syndrome when symptoms persist, recur, interfere with daily life or do not improve as expected. Seek urgent help sooner for warning signs.
Summary
Premenstrual syndrome is a recurring group of physical and emotional symptoms in the luteal phase that improve after menstruation begins. Individual assessment, evidence-informed treatment and clear urgent-care guidance support safe, respectful decisions.
References and further reading
These official resources provide further guidance relevant to premenstrual syndrome. Recommendations can change, and local professional advice should guide individual care.
OUR REVIEW PROMISE
Evidence-based, clearly reviewed.
Healthier Baby Today articles are reviewed for accuracy and updated as guidance changes.
Last updated: July 17, 2026
